Mycetoma is a chronic, progressively destructive morbid inflammatory disease usually of the foot but any part of the body can be affected. Infection is most probably acquired by traumatic inoculation of certain fungi or bacteria into the subcutaneous tissue. Mycetoma was described in the modern literature in 1694 but was first reported in the mid-19th century in the Indian town of Madura, and hence was initially called Madura foot.
Mycetoma commonly affects young adults, particularly males aged between 20 and 40 years, mostly in developing countries. People of low socioeconomic status and manual workers such as agriculturalists, labourers and herdsmen are the worst affected.
Mycetoma has numerous adverse medical, health and socioeconomic impacts on patients, communities and health authorities.
As mycetoma is a badly neglected disease, accurate data on its incidence and prevalence are not available. However, as in the case of Buruli ulcer, early detection and treatment are important to reduce morbidity and improve treatment outcomes.
The causative organisms of mycetoma are distributed worldwide but are endemic in tropical and subtropical areas in the ‘Mycetoma belt’, which includes the Bolivarian Republic of Venezuela, Chad, Ethiopia, India, Mauritania, Mexico, Senegal, Somalia, Sudan and Yemen.
Transmission occurs when the causative organism enters the body through minor trauma or a penetrating injury, commonly thorn pricks. There is a clear relationship between mycetoma and individuals who walk barefooted and are manual workers. The disease is common among barefoot populations who live in rural areas in endemic regions but no person is exempted.
Mycetoma is characterized by a triad of painless subcutaneous mass, multiple sinuses and discharge containing grains. It usually spreads to involve the skin, deep structures and bone resulting in destruction, deformity and loss of function, which may be be fatal. Mycetoma commonly involves the extremities, back and gluteal region.
Given its slow progression, painless nature, massive lack of health education and scarcity of medical and health facilities in endemic areas, many patients present late with advanced infection where amputation may be the only available treatment. Secondary bacterial infection is common, and lesions may cause increased pain and disability and fatal septicaemia (severe infections involving the entire human system) if untreated. Infection is not transmitted from human to human.
The causative organisms can be detected by examining surgical tissue biopsy as well the lesion sinuses discharge. Although grains microscopy is helpful in detecting the characteristic grains, it is important to culture them to identify the causative organism properly. There are other useful techniques for the diagnosis of mycetoma and that included DNA sequencing and many imaging techniques. All these tests are not commonly available in endemic areas. There are no simple friendly used diagnostic tests to use in mycetoma endemic villages.
The treatment depends on the causative organisms for the bacterial; it is a long term antibiotics combination whereas for fungal type it is combined antifungals drugs and surgery. The treatment is unsatisfactory, has many side effects, expensive and not available in endemic areas.
Prevention & Control
Mycetoma is not a notifiable disease (a disease required by law to be reported) and no surveillance systems exist. There no preventable or control programmes for mycetoma yet. Preventing infection is difficult, but people living in or travelling to endemic areas should be advised not to walk barefooted.